Abstract
LBA45 - Top-line results from SUNRISE: A phase III, randomized, double-blind, placebo-controlled multicenter trial of bavituximab plus docetaxel in patients with previously treated stage IIIb/iv non-squamous non-small cell lung cancer
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have